Ameliorating effect of calycosin regulating SIRT3/SOD2 signaling pathway on airway epithelial cell damage in mice

doi:10.11958/20240829

Abstract

Abstract:

Objective To investigate effects of calycosin (CA) on cigarette smoke (CS) induced airway epithelial cell damage in mice and the sirtuin 3/superoxide dismutase 2 (SIRT3/SOD2) signaling pathway in mice. Methods A total of 90 mice were randomly separated into the control group, the cigarette smoke (CS) group, the CA low-dose treatment group (CA-L group), the CA high-dose treatment group (CA-H group) and the CA high-dose treatment plus SIRT3 inhibitor 3-TYP group (CA-H+3-TYP group), with 18 mice in each group. Tidal volume (TV) and peak expiratory flow rate (PEF) of lung function were detected by whole body plethysmography system. Serum levels of inflammatory factors [interleukin (IL) -6, tumor necrosis factor (TNF) -α] and oxidative stress indicators [reactive oxygen species (ROS), SOD] were detected by enzyme-linked immunosorbent assay (ELISA). The injury of airway epithelial cells in lung tissue was observed by HE staining. The expression levels of barrier related proteins (OCLN and ZO-1) in airway epithelial cells were detected by immunohistochemistry. Immunoblotting was applied to detect the expression of SIRT3/SOD2 signaling pathway related proteins. Results Compared with the control group, levels of TV, PEF, MAN and SOD and the expression levels of OCLN, ZO-1, SIRT3 and SOD2 were decreased in the CS group, while the levels of MLI, IL-6, TNF-α and ROS were increased (P<0.05). Compared with the control group, the lung tissue structure was significantly damaged, the alveolar enlargement was obvious, the surrounding alveolar was accompanied by inflammatory cell infiltration, and the airway epithelial cells were obviously shed in the CS group. Different doses of CA alleviated lung tissue destruction, improved alveolar structure, reduced inflammatory cell infiltration, reduced airway epithelial cell shedding, increased levels of TV, PEF, MAN, SOD and OCLN, ZO-1, SIRT3 and SOD2, and decreased levels of MLI, IL-6, TNF-α and ROS. The effect of high dose CA was more significant than that of low dose CA (P<0.05). SIRT3/SOD2 signaling pathway inhibitor 3-TYP partially reversed the ameliorative effect of CA on CS induced airway epithelial cell injury in mice. Conclusion CA can ameliorate CS induced airway epithelial cell damage in mice, and its mechanism is related to the activation of the SIRT3/SOD2 signaling pathway.

Key words: calycosin, smog, Sirtuin 3/superoxide dismutase 2, damage to airway epithelial cells

CLC Number:

R562.22

Figures/Tables 8

References 25

[1]	SIROCKO K T, ANGSTMANN H, PAPENMEIRE S, et al. Early-life exposure to tobacco smoke alters airway signaling pathways and later mortality in D. melanogaster[J]. Environ Pollut, 2022, 309(1):119696-119706. doi:10.1016/j.envpol.2022.119696.
[2]	中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版)[J]. 中华结核和呼吸杂志, 2021, 44(3):170-205.
	Chronic Obstructive Pulmonary Disease Group, Respiratory Medicine Branch, Chinese Medical Association, Working Committee of Chronic obstructive Pulmonary Disease, Respiratory Medicine Branch,Chinese Medical Doctor Association. Guidelines for diagnosis and treatment of chronic obstructive pulmonary disease (2021 revised edition)[J]. Chinese Journal of Tuberculosis and Respiratory, 2021, 44(3):170-205. doi:10.3760/cma.j.cn112147-20210109-00031.
[3]	BRENNAN M, MCDONNELL M J, HARRISON M J, et al. Antimicrobial therapies for prevention of recurrent acute exacerbations of COPD (AECOPD):beyond the guidelines[J]. Respir Res, 2022, 23(1):58-68. doi:10.1186/s12931-022-01947-5.
[4]	WANG C, LUO J, BAI X, et al. Calycosin alleviates injury in airway epithelial cells caused by PM 2.5 exposure via activation of AMPK signalling[J]. Evid Based Complement Alternat Med, 2021, 2021(1):8885716-8885724. doi:10.1155/2021/8885716.
[5]	LI F, YE C, WANG X, et al. Honokiol ameliorates cigarette smoke-induced damage of airway epithelial cells via the SIRT3/SOD2 signalling pathway[J]. J Cell Mol Med, 2023, 27(24):4009-4020. doi:10.1111/jcmm.17981.
[6]	AGHAPOUR M, RAEE P, MOGHADDAM S J, et al. Airway epithelial barrier dysfunction in chronic obstructive pulmonary disease:role of cigarette smoke exposure[J]. Am J Respir Cell Mol Biol, 2018, 58(2):157-169. doi:10.1165/rcmb.2017-0200TR.
[7]	LIANG W, ZHAO C, CHEN Z, et al. Sirtuin-3 protects cochlear hair cells against noise-induced damage via the superoxide dismutase 2/reactive oxygen species signaling pathway[J]. Front Cell Dev Biol, 2021, 9(1):766512-766523. doi:10.3389/fcell.2021.766512.
[8]	张蓝熙, 田燕歌, 朱丽华, 等. 补肺益肾方通过调控Nrf2通路抗氧化应激治疗慢性阻塞性肺疾病机制[J]. 中华中医药杂志, 2020, 35(5):2374-2379.
	ZHANG L X, TIAN Y G, ZHU L H, et al. Mechanism of Bufei Yishhen formula in treating chronic obstructive pulmonary disease by regulating Nrf2 pathway against oxidative stress[J]. Chinese Journal of Traditional Chinese Medicine, 2020, 35(5):2374-2379.
[9]	CHRISTENSON S A, SMITH B M, BAFADHEL M, et al. Chronic obstructive pulmonary disease[J]. Lancet, 2022, 399(10342):2227-2242. doi:10.1016/S0140-6736(22)00470-6.
[10]	王玉君, 韩波妮, 史艳平, 等. 毛蕊异黄酮对呼吸道合胞病毒感染致肺炎模型小鼠的保护作用及机制研究[J]. 中药材, 2022, 45(3):715-719.
	WANG Y J, HAN B N, SHI Y P, et al. Protective effect and mechanism of mullein isoflavone on respiratory syncytial virus induced pneumonia in mice[J]. Chinese Traditional Medicine, 2022, 45(3):715-719. doi:10.13863/j.issn1001-4454.2022.03.035.
[11]	岳琳莹, 赵永忠, 杨晓金, 等. 毛蕊异黄酮对大鼠呼吸机相关性肺损伤的影响及其与HB-EGF的关系[J]. 中华麻醉学杂志, 2020, 40(9):1142-1146.
	YUE L Y, ZHAO Y Z, YANG X J, et al. Effects of calydrin on ventilator associated lung injury in rats and its relationship with HB-EGF[J]. Chinese Journal of Anesthesiology, 2020, 40(9):1142-1146. doi:10.3760/cma.j.cn131073.20191130.00926.
[12]	赵术彤, 丁运, 李月川, 等. 轻度慢性阻塞性肺疾病的病理特征及其与炎性因子的相关性[J]. 天津医药, 2024, 52(6):643-647.
	ZHAO S T, DING Y, LI Y C, et al. Pathological characteristics of mild chronic obstructive pulmonary disease and its correlation with inflammatory factors[J]. Tianjin Med J, 2024, 52(6):643-647. doi:10.11958/20231360.
[13]	侯亚儒, 舒新乐, 张霞, 等. PARP-1抑制剂通过激活SIRT1-PGC-1α轴减轻慢性阻塞性肺疾病大鼠的炎症和氧化应激反应[J]. 中国免疫学杂志, 2023, 39(12):2540-2544.
	HOU Y R, SHU X L, ZHANG X, et al. PARP-1 inhibitors reduce inflammation and oxidative stress in rats with chronic obstructive pulmonary disease by activating SIRT1-PGC-1α axis[J]. Chinese Journal of Immunology, 2023, 39(12):2540-2544. doi:10.3969/j.issn.1000-484X.2023.12.014.
[14]	聂进, 刘代顺, 张建勇, 等. 脐带间充质干细胞外泌体对慢性阻塞性肺疾病大鼠肺部炎症的作用机制探讨[J]. 天津医药, 2023, 51(12):1326-1331.
	NIE J, LIU D S, ZHANG J Y, et al. Effect of umbilical cord mesenchymal stem cell exosomes on pulmonary inflammation in rats with chronic obstructive pulmonary disease[J]. Tianjin Med J, 2023, 51(12):1326-1331. doi:10.11958/20230708.
[15]	HUANG H, HUANG X, ZENG K, et al. Interleukin-6 is a strong predictor of the frequency of COPD exacerbation within 1 year[J]. Int J Chron Obstruct Pulmon Dis, 2021, 16(1):2945-2951. doi:10.2147/COPD.S332505.
[16]	HUANG X, GUAN W, XIANG B, et al. MUC5B regulates goblet cell differentiation and reduces inflammation in a murine COPD model[J]. Respir Res, 2022, 23(1):11-22. doi:10.1186/s12931-021-01920-8.
[17]	DANG X, HE B, NING Q, et al. Alantolactone suppresses inflammation,apoptosis and oxidative stress in cigarette smoke-induced human bronchial epithelial cells through activation of Nrf2/HO-1 and inhibition of the NF-κB pathways[J]. Respir Res, 2020, 21(1):95-105. doi:10.1186/s12931-020-01358-4.
[18]	CARLIER F M, DE FAYS C, PILETTE C. Epithelial barrier dysfunction in chronic respiratory diseases[J]. Front Physiol, 2021, 12(1):691227-691253. doi:10.3389/fphys.2021.691227.
[19]	江宇航, 梅晓峰, 贾利丹, 等. 香烟烟雾诱导慢性阻塞性肺疾病模型小鼠气道上皮屏障损伤的机制[J]. 中国病理生理杂志, 2022, 38(7):1297-1303.
	JIANG Y H, MEI X F, JIA L D, et al. Mechanism of airway epithelial barrier injury induced by cigarette smoke in mice model of chronic obstructive pulmonary disease[J]. Chinese Journal of Pathophysiology, 2022, 38(7):1297-1303. doi:10.3969/j.issn.1000-4718.2022.07.018.
[20]	杨学敏, 张欢欢, 宋立强. 柚皮苷通过减轻氧化应激降低急性肺损伤小鼠内皮通透性的研究[J]. 现代药物与临床, 2023, 38(10):2389-2396.
	YANG X M, ZHANG H H, SONG L Q. Effects of naringin on endothelial permeability in mice with acute lung injury by alleviating oxidative stress[J]. Modern Medicine and Clinic, 2023, 38(10):2389-2396. doi:10.7501/j.issn.1674-5515.2023.10.002.
[21]	SONG Y, FU W, ZHANG Y, et al. Azithromycin ameliorated cigarette smoke-induced airway epithelial barrier dysfunction by activating Nrf2/GCL/GSH signaling pathway[J]. Respir Res, 2023, 24(1):69-88. doi:10.1186/s12931-023-02375-9.
[22]	WANG T, CAO Y, ZHENG Q, et al. SENP1-SIRT3 signaling controls mitochondrial protein acetylation and metabolism[J]. Mol Cell, 2019, 75(4):823-834. doi:10.1016/j.molcel.2019.06.008.
[23]	訾亚婉, 廖科, 陈虹. 烟草烟雾通过ROS/Sirt3/SOD2通路诱导NSCLC细胞吉非替尼耐药[J]. 中国肺癌杂志, 2023, 26(4):245-256.
	ZI Y W, LIAO K, CHEN H. Tobacco smoke induces gefitinib resistance in NSCLC cells through ROS/Sirt3/SOD2 pathway[J]. Chinese Journal of Lung Cancer, 2023, 26(4):245-256. doi:10.3779/j.issn.1009-3419.2023.106.05.
[24]	ZHANG M, ZHANG Y, ROTH M, et al. Sirtuin 3 inhibits airway epithelial mitochondrial oxidative stress in cigarette smoke-induced COPD[J]. Oxid Med Cell Longev, 2020, 2020(1):7582980-7582991. doi:10.1155/2020/7582980.
[25]	廖贞亮, 冯帮海, 任颖聪, 等. 沉默信息调节因子2相关酶3调控自噬减轻H₂O₂诱导的肺泡Ⅱ型上皮细胞凋亡[J]. 实用医学杂志, 2023, 39(11):1389-1395.
	LIAO Z L, FENG B H, REN Y C, et al. Silencing regulator 2 related enzyme 3 regulates autophagy and reduces H2O2-induced apoptosis of alveolar type Ⅱ epithelial cells[J]. Journal of Practical Medicine, 2023, 39(11):1389-1395. doi:10.3969/j.issn.1006-5725.2023.11.012.

组别	TV/（mL/s）	PEF/（mL/s）
Control组	0.29±0.03	5.22±0.22
CS组	0.17±0.02^a	3.85±0.15^a
CA-L组	0.22±0.02^b	4.46±0.18^b
CA-H组	0.28±0.03^bc	5.13±0.20^bc
CA-H+3-TYP组	0.21±0.02^d	4.27±0.16^d
F	75.900^＊	780.549^＊

组别	TV/（mL/s）	PEF/（mL/s）
Control组	0.29±0.03	5.22±0.22
CS组	0.17±0.02^a	3.85±0.15^a
CA-L组	0.22±0.02^b	4.46±0.18^b
CA-H组	0.28±0.03^bc	5.13±0.20^bc
CA-H+3-TYP组	0.21±0.02^d	4.27±0.16^d
F	75.900^＊	780.549^＊

组别	IL-6/ （ng/L）	TNF-α/ （ng/L）	ROS/ （U/mL）	SOD/ （U/mL）
Control组	55.37±2.84	5.29±1.27	136.87±5.22	89.62±3.96
CS组	143.51±4.06^a	18.25±2.59^a	205.34±7.96^a	41.32±2.25^a
CA-L组	108.46±3.58^b	12.11±1.46^b	172.45±6.84^b	62.57±2.89^b
CA-H组	72.47±3.06^bc	6.04±1.33^bc	143.86±5.61^bc	84.39±3.71^bc
CA-H+ 3-TYP组	124.71±3.79^d	14.38±2.51^d	183.22±7.07^d	53.41±2.63^d
F	653.213^＊	49.481^＊	109.558^＊	252.394^＊

组别	IL-6/ （ng/L）	TNF-α/ （ng/L）	ROS/ （U/mL）	SOD/ （U/mL）
Control组	55.37±2.84	5.29±1.27	136.87±5.22	89.62±3.96
CS组	143.51±4.06^a	18.25±2.59^a	205.34±7.96^a	41.32±2.25^a
CA-L组	108.46±3.58^b	12.11±1.46^b	172.45±6.84^b	62.57±2.89^b
CA-H组	72.47±3.06^bc	6.04±1.33^bc	143.86±5.61^bc	84.39±3.71^bc
CA-H+ 3-TYP组	124.71±3.79^d	14.38±2.51^d	183.22±7.07^d	53.41±2.63^d
F	653.213^＊	49.481^＊	109.558^＊	252.394^＊

组别	MAN/（个/mm²）	MLI/μm
Control组	57.22±2.76	97.68±5.16
CS组	22.89±1.39^a	183.52±7.92^a
CA-L组	38.47±1.84^b	147.23±6.74^b
CA-H组	55.81±2.41^bc	109.49±5.53^bc
CA-H+3-TYP组	31.85±1.65^d	161.37±7.05^d
F	314.527^＊	178.716^＊